Form 4: CareDx Executive Alexander L. Johnson Sells Shares After Option Exercise

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., executed stock options and subsequently sold shares on August 20 and 21, 2024.

Summary

• On August 20 and 21, 2024, Alexander L. Johnson, an officer at CareDx, Inc., exercised employee stock options to acquire a total of 61,023 shares of common stock.
• Following the exercise of these options, Johnson sold 39,466 shares on August 20 at a weighted average price of $33.17, and 21,557 shares on August 21 at a weighted average price of $32.58.
• The exercise price for the options was $23.48 per share.
• After these transactions, Johnson directly owns 284,983 shares of CareDx common stock.
• The options vest over time, with a portion vesting on June 16, 2023, and the remainder vesting monthly until fully vested.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The executive exercised options and sold shares, which could be for various personal financial reasons and doesn't necessarily reflect a positive or negative view of the company.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which investors often monitor for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The information disclosed is consistent with regulatory requirements for insider trading reporting.
• Comparable companies such as Natera, Inc. and Exact Sciences Corp also have executives who file Form 4s when they trade company stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders as insider trading activity is often scrutinized.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates